News

Keep up-to-date on drug shortages, new ANDAs and NDAs, Nexus Milestones and more.

Our mission drives everything we do. We develop, advance and deploy life-saving, critical-need drugs to institutions that depend on them every day.

Nexus Pharmaceuticals Announces FDA Approval of Dicyclomine HCl Injection, USP

February 14, 2019

Nexus Pharmaceuticals announced today it has received U.S. Food and Drug Administration (FDA) approval for Dicyclomine Hydrochloride (HCl) Injection, USP in 20mg/2mL vial, the generic equivalent to Bentyl®...

Read more

Nexus Pharmaceuticals Announces FDA Approval of Busulfan Injection

January 16, 2019

Nexus Pharmaceuticals Inc. announced today the U.S. Food and Drug Administration (FDA) approval of Busulfan Injection, the company's AP-rated therapeutic equivalent for Busulfex®...

Read more

Nexus Pharmaceuticals Receives FDA Approval for Arsenic Trioxide Injection in 10mg per 10mL Vial

November 15, 2018

Nexus Pharmaceuticals announced today the immediate availability in the United States for Arsenic Trioxide Injection. Nexus Pharmaceuticals’ Arsenic Trioxide Injection...

Read more

Nexus Pharmaceuticals Receives FDA Approval for Procainamide HCL Injection

October 19, 2017

Nexus Pharmaceuticals announced today the immediate availability in the United States of Procainamide HCL Injection, USP. Nexus Pharmaceuticals' Procainamide...

Read more

Nexus Pharmaceuticals Receives FDA Approval for Isoproterenol Injection

August 3, 2017

Nexus Pharmaceuticals announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug...

Read more

Nexus Pharmaceuticals Receives FDA Approval for Sodium Nitroprusside Injection

May 31, 2017

Nexus Pharmaceuticals announced today the immediate availability in the United States of Sodium Nitroprusside Injection. Nexus Pharmaceuticals’ Sodium Nitroprusside...

Read more